AstraZeneca entered into an exclusive global license agreement with China’s Dizal Pharmaceutical for the lung cancer ...

By Kunal Das and Christy Santhosh July 14 (Reuters) - The U.S. FDA has approved Celcuity's drug for an advanced form of ...

London-listed AstraZeneca said it entered into an exclusive global license agreement with Dizal for lung cancer treatment drug Zegfrovy, offering an upfront payment of $600 millio ...

Mesothelioma is a rare but aggressive cancer, usually caused by exposure to asbestos. Inhaled asbestos fibers become lodged ...

A preclinical study finds that combining atovaquone with platelet-derived growth factor receptor inhibitors reduced ovarian cancer tumoroid viability.

July 10 (Reuters) - British drugmaker GSK said on Friday its experimental drug for treating patients with advanced or ...

A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...

Pancreatic cancer is considered one of the most lethal cancer because it is often diagnosed late and is difficult to treat.

Revtorpyk is intended to treat patients with advanced breast cancer whose tumors have low levels of a protein called HER2 and ...

Nearly a decade after spinning out its Chinese research hub to form Dizal Pharmaceutical, AstraZeneca is paying up to $1.5 billion to buy a piece of the pipeline, securing exclusive global rights for ...

Scientists have cracked how bacteria build cancer-fighting compounds, a breakthrough that could speed up new treatments. The ...

Mesothelioma is a rare but aggressive cancer, usually caused by exposure to asbestos. Inhaled asbestos fibers become lodged ...